Paxlovid and Methocarbamol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paxlovid (nirmatrelvir; ritonavir) and Methocarbamol (methocarbamol). Common drug interactions include confusional state among females and acute myeloid leukaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Paxlovid and Methocarbamol. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Paxlovid?

Paxlovid has active ingredients of nirmatrelvir; ritonavir. eHealthMe is studying from 38,421 Paxlovid users. Check the latest studies of Paxlovid.

What is Methocarbamol?

Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.



On Jul, 13, 2026

28 people who take Paxlovid and Methocarbamol together, and have interactions are studied.

Paxlovid and Methocarbamol drug interactions.

What are the common drug interactions of Paxlovid and Methocarbamol, by gender? *:

female:

  1. Confusional state
  2. Decreased appetite
  3. Diarrhoea
  4. Disease recurrence
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Cellulitis (infection under the skin)
  7. Dysgeusia (disorder of the sense of taste)
  8. Faeces discoloured
  9. Hospitalisation
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  2. Arthralgia (joint pain)
  3. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  4. Oropharyngeal pain
  5. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  6. Rhinorrhoea (watery mucus discharge from the nose)
  7. Urine output increased
  8. White blood cell count increased
  9. Dysgeusia (disorder of the sense of taste)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Paxlovid and Methocarbamol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cellulitis (infection under the skin)
  2. Disease recurrence
  3. Retching (strong involuntary effort to vomit)
  4. Rotator cuff repair
  5. Sleep disorder
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Dysgeusia (disorder of the sense of taste)
  8. Ear discomfort
  9. Urine output increased

50-59:

  1. Confusional state
  2. Decreased appetite
  3. Diarrhoea
  4. Faeces discoloured
  5. Nausea (feeling of having an urge to vomit)
  6. Blood glucose increased
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Cough
  9. Disease recurrence
  10. Dizziness

60+:

  1. Hospitalisation
  2. Arthralgia (joint pain)
  3. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  4. Rebound effect (take-back effect)
  5. Rhinorrhoea (watery mucus discharge from the nose)
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. White blood cell count increased
  8. Disease recurrence
  9. Dysgeusia (disorder of the sense of taste)
  10. Femur fracture

What are the existing conditions these people have? *

  1. Pain: 6 people, 21.43%
  2. Diabetes: 5 people, 17.86%
  3. Migraine (headache): 4 people, 14.29%
  4. High Blood Cholesterol: 4 people, 14.29%
  5. Sleep Disorder: 4 people, 14.29%
  6. Hypersensitivity: 4 people, 14.29%
  7. Depression: 4 people, 14.29%
  8. Back Pain: 3 people, 10.71%
  9. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 10.71%
  10. Neuralgia (pain in one or more nerves): 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Paxlovid and Methocarbamol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Paxlovid and Methocarbamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Paxlovid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methocarbamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paxlovid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methocarbamol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nirmatrelvir; ritonavir and methocarbamol (the active ingredients of Paxlovid and Methocarbamol, respectively), and Paxlovid and Methocarbamol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: